Events & Presentations

Date	Event Details	Remind Me
Apr 3 - Apr 4, 2023	7th Complement UK Training Course and Symposium	Add to Outlook Add to Google Calendar

Date	Event Details
Feb 2, 2022 4:30 PM EST	Arrowhead Pharmaceuticals 2022 First Quarter Results Listen to webcast Supporting Materials: Prepared Remarks 206.2 KB
Dec 3, 2021	18th Global Cardiovascular Clinical Trialists Forum Supporting Materials: View Presentation 1.1 MB View Additional Information James Hamilton, MD, MBA, Arrowhead’s senior vice president of discovery & translational medicine, will participate in a panel discussion titled, “Developments in Hypertriglyceridemia Trials”
Dec 2, 2021 1:00 PM EST	4th Annual Evercore ISI HealthCONx Conference Listen to webcast View Additional Information Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Nov 30, 2021	Piper Sandler 33rd Annual Healthcare Conference Listen to webcast View Additional Information Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Nov 22, 2021 4:30 PM EST	Arrowhead Pharmaceuticals 2021 Year End Results Listen to webcast Supporting Materials: Prepared Remarks 210.1 KB
Nov 16, 2021 11:50 AM EST	Jefferies London Healthcare Conference View Additional Information Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Nov 13 - Nov 17, 2021	American Heart Association (AHA) Scientific Sessions 2021 Supporting Materials: American Heart Association (AHA) Scientific Sessions 2021 659.9 KB View Additional Information Title: ARO-APOC3, an Investigational RNAi Therapeutic, Shows Similar Efficacy and Safety in Genetically Confirmed FCS and Non-FCS Participants with Severe Hypertriglyceridemia Authors: Christie Ballantyne, presenting on behalf of Peter Clifton, et al. Session: The Future of Lipidology: Novel and Emerging Interventions for Lipid Disorders
Nov 12 - Nov 15, 2021	The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Supporting Materials: AASLD 2021 AROAAT2002 poster 1.3 MB AASLD 2021 AROHSD1001 poster 1.5 MB AASLD 2021 REEF-1 Late-Breaker Oral 484.5 KB View Additional Information Title: ARO-AAT Treatment Reduces Intra-hepatic Z-AAT Leading to Improved Parameters of Liver Health and Fibrosis Regression Authors: Pavel Strnad, et al. Publication Number: LP11 Session: Late-breaking Abstract Posters Title: ARO-HSD, An Investigational RNAi Therapeutic, Demonstrates Reduction in ALT and Hepatic HSD17B13 mRNA and Protein in Patients with NASH or Suspected NASH Authors: Lung-Yi Mak, et al. Publication Number: LP13 Session: Late-breaking Abstract Posters Title: Efficacy and Safety of the siRNA JNJ-3989 and/or the Capsid Assembly Modulator (CAM) JNJ-6379 for the Treatment of Chronic Hepatitis B Virus Infection (CHB): Results from the Phase 2B REEF-1 Study Authors: Man Fung Yuen, et al. Publication Number: LO10 Session: Late Breaking Session 2
Oct 26, 2021 3:00 PM EDT	ARO-C3 KOL Webinar Register for webcast Supporting Materials: View Presentation 3.8 MB
Oct 12, 2021 2:00 PM EDT	H.C. Wainwright 5th Annual NASH Investor Conference Listen to webcast View Additional Information James Hamilton, M.D., MBA, Arrowhead’s senior vice president of discovery and translational medicine will participate in a fireside chat presentation